Partners
CLARITY brings together expertise in immunology, genetics, network biology, virology, clinical research and patient engagement. Learn more about our partners.
University Medical Center Utrecht, Netherlands uitklapper, klik om te openen
UMC Utrecht is an academic medical centre combining patient care, research and education. As coordinator of CLARITY, its researchers study the immunological and cellular mechanisms linking RSV infection to later respiratory disease and use patient-derived airway organoids to investigate disease mechanisms and potential treatments.
Helmholtz Zentrum München, Germany uitklapper, klik om te openen
Helmholtz Munich is a biomedical research centre focused on developing solutions for the prevention and treatment of common diseases. Its Institute of Network Biology contributes expertise in virus-host interactions, protein networks and computational approaches to understand how RSV changes molecular processes in human cells.
Institute for Research in Biomedicine (IRB Barcelona), Spain uitklapper, klik om te openen
IRB Barcelona is a biomedical research institute that studies fundamental biological mechanisms underlying disease. Within CLARITY, the Structural Bioinformatics and Network Biology team contributes computational and network-based approaches to integrate molecular data and identify biological pathways and potential therapeutic targets.
Instituto De Salud Carlos III, Spain uitklapper, klik om te openen
The Instituto de Salud Carlos III (ISCIII) is Spain's national public research organisation for biomedicine and public health. CLARITY researchers at its National Centre for Microbiology contribute expertise in respiratory viruses, including the genetic characterisation and surveillance of RSV strains.
Servicio Madrileño De Salud, Spain uitklapper, klik om te openen
The Servicio Madrileño de Salud (SERMAS) manages the public healthcare services and hospital network of the Community of Madrid. Within CLARITY, clinical researchers from its hospitals contribute expertise and patient data from Spanish paediatric cohorts to study severe RSV infection and its possible long-term respiratory consequences.
Participating hospitals:
Hospital Universitario La Paz, Spain
Hospital Universitario Severo Ochoa, Spain
University of Tartu, Estonia uitklapper, klik om te openen
The University of Tartu's Institute of Genomics conducts research using genomic and health data and maintains the Estonian Biobank. In CLARITY, researchers use large-scale genetic and medical data to investigate why some people may be more susceptible to severe RSV infection and later chronic respiratory disease.
ReSViNET Foundation, Netherlands uitklapper, klik om te openen
ReSViNET Foundation is an international non-profit organisation dedicated to reducing the global burden of RSV through research, education, awareness and collaboration. Within CLARITY, ReSViNET connects the project with patients and other stakeholders through its RSV Patient Network and supports patient involvement, stakeholder engagement and communication activities.
Visit the Patients page to learn more about how we engage with patients.
